Blog from IFPMA ADG Greg Perry following his visit to Cabo Verde
Find out here an insight that Greg Perry gives around WHO Afro Global Health Forum 2019
Read More
Thought Leader Series in Vaccines
A mustread from experts talking about the value of vaccines
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2021-01-25 07:00:01
Biopharmaceutical global body kicks off 2021 with new CEO leadership line up
Geneva, 25 January 2021 –The biopharmaceutical global industry, represented by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), is pleased ...
Read More2021-01-12 11:27:48
Speak Up Africa and IFPMA start their search for winners of the Africa Young Innovators for Health Award
The Africa Young Innovators for Health Award is IFPMA and Speak Up Africa’s flagship programme ...
Read More2020-12-08 12:45:58
Speak Up Africa and IFPMA launch the “Africa Young Innovators for Health Award” to fuel innovation and help advance promising healthcare solutions
The first edition of the “Africa Young Innovators for Health Award” aims to support entrepreneurs ...
Read More2020-12-08 08:09:19
Pharma innovation delivers COVID-19 solutions beyond expectations, but calls for the dilution of intellectual property rights are counterproductive
8 December 2020, Geneva — The biopharmaceutical industry has made the fight against the COVID-19 ...
Read More2020-12-07 08:40:06
A broad alliance, a crucial mission: A new multi-stakeholder association to combat falsified medicines
Seven years since its first activities as a grass-roots advocacy campaign, Fight the Fakes announces ...
Read More2020-11-10 15:41:24
Innovative and generic & biosimilar pharmaceutical industries unite on commitment to equitable access to COVID-19 medicines and vaccines, while flagging where further help is needed from others
Geneva 10 November 2020 – On the occasion of the World Health Assembly, the world’s ...
Read More2020-10-22 09:38:06
IFPMA launches Note for Guidance to help those acting on behalf of biopharmaceutical companies live up to its ethical business principles
GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers and Associations (IFPMA) published today ...
Read More
Latest Statement
2021-01-20 11:00:22
IFPMA, GSCF, ICBA Joint Statement on the item 14.2 Strengthening preparedness for health emergencies: implementation of the IHR @EB148
Mr Chairman, IFPMA welcomes and supports the ongoing work and interim findings of the Review Committee on the Functioning of ...
Read More2021-01-19 08:25:31
IFPMA Statement for EB148 agenda item 14.1 Covid-19 Response
GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers ...
Read More2021-01-13 08:17:19
Innovative biopharmaceutical industry comment on COVID-19 vaccines dosing strategies and recommend following the science
GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers ...
Read More2020-12-07 09:15:51
IFPMA Welcomes New Fight the Fakes Alliance
GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers ...
Read More2020-11-20 14:00:59
Biopharmaceutical representative joins new antibiotic resistance fighting United Nations group to avert looming superbugs public health
GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers ...
Read More2020-11-18 10:00:15
Joint Statement On World Antimicrobial Awareness Week
GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers ...
Read More2020-11-09 21:42:14
IFPMA/IGBA “Considerations on equitable access to COVID-19 medicines and vaccines”
GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers ...
Read More
mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig
Sadia Kaenzig - Communications Manager
Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.
mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol
Morgane De Pol - Communications and Public Affairs
Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
Hot Topic
Pharmacovigilance: Do your bit, play your part!
Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is
Read MoreInterview
IFPMA 2015 interview series 'Biodiversity, human health, and pharma'
A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to
Read MoreOur Blog
The road to building trust in COVID-19 vaccines
This oped was originally published on Media Planet Vaccine Awareness Campaign on 22 December 2020 Vaccines are one of the most cost effective interventions we have to safeguard public health and yet during this pandemic we have seen a decrease in public confidence. The latest World Economic Forum/Ipsos survey found that the number of people willing to get a COVID-19 vaccine has dropped to 73%...
Read More
COVID-19 diagnostics, treatments and vaccines: Progress achieved in 2020 and insights into 2021 and beyond
Last week, IFPMA hosted the fifth and last CEO COVID-19 media briefing of 2020 with CEOs and top executives from Eli Lilly and Company, Johnson & Johnson, Pfizer and Roche. I joined the CEOs as they shared their take on progress achieved in 2020 and insights into 2021 and beyond. With this blog, I wanted to share with you some of the highlights of the...
Read More
How vaccinations help protect all ages of the population
This oped was originally published on Media Planet Value of Vaccines Q4 2020 Campaign on 10 December 2020 The COVID-19 pandemic has reminded us how vulnerable the world is in the face of deadly pathogens. Vaccines have been an essential tool offering protection from diseases like diphtheria, tetanus, pneumonia, and polio, diseases that once harmed or killed thousands of children every year. Thanks to these...
Read MoreLatest Tweets
